2025-2026 Regular Session • New York Legislature
S04459
Legislative Summary
Adds W-18(4-chloro-N-1-2-(4-nitrophenyl)ethyl 2piperidinylidenebenzenesulfonamide) to the schedule of controlled substances.
Demographic Impact
Overall analysis of equity impact
70% Bias
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/5/2025
REFERRED TO HEALTH
Senate
Status Information
Current Status
Introduced(2/5/2025)
Chamber
Senate
Committee
Health(Senate)
Sponsors
Democrat: 1
Primary Sponsor
James Skoufis
Democrat